IIM
VRTX icon

Ipswich Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Ipswich Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Sell
1,163
-900
-44% -$399K 0.12% 119
2026
Q1 		$921K Buy
2,063
+20
+1% +$9.33K 0.22% 88
2025
Q4 		$926K Sell
2,043
-40
-2% -$17.2K 0.21% 87
2025
Q3 		$816K Sell
2,083
-3,525
-63% -$1.47M 0.19% 95
2025
Q2 		$2.5M Buy
5,608
+90
+2% +$41.5K 0.6% 40
2025
Q1 		$2.68M Buy
5,518
+510
+10% +$238K 0.66% 40
2024
Q4 		$2.02M Buy
5,008
+3,485
+229% +$1.62M 0.49% 50
2024
Q3 		$708K Buy
1,523
+40
+3% +$19.2K 0.16% 107
2024
Q2 		$695K Buy
1,483
+190
+15% +$82.5K 0.16% 105
2024
Q1 		$540K Buy
1,293
+508
+65% +$215K 0.13% 126
2023
Q4 		$319K Buy
+785
New +$290K 0.08% 150
2021
Q3 		– Sell
-3,875
Closed -$781K – 200
2021
Q2 		$781K Sell
3,875
-2,445
-39% -$511K 0.2% 107
2021
Q1 		$1.36M Buy
+6,320
New +$1.39M 0.38% 75
2014
Q3 		– Sell
-3,685
Closed -$349K – 144
2014
Q2 		$349K Sell
3,685
-1,460
-28% -$102K 0.14% 106
2014
Q1 		$364K Sell
5,145
-8,966
-64% -$710K 0.16% 93
2013
Q4 		$1.05M Sell
14,111
-1,985
-12% -$138K 0.44% 58
2013
Q3 		$1.22M Sell
16,096
-369
-2% -$29.4K 0.55% 55
2013
Q2 		$1.32M Buy
+16,465
New +$1.21M 0.57% 57

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Ipswich Investment Management's VRTX Position: Q2 2026 in Review

Ipswich Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 44% in Q2 2026, selling an estimated $399K and leaving 1,163 shares worth $578K. The position accounts for 0.12% of the portfolio, ranked #119.

Ipswich Investment Management first reported a position in VRTX in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.68M in Q1 2025. 337 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ipswich Investment Management held 1,163 shares of Vertex Pharmaceuticals worth $578K as of Q2 2026.
  • Ipswich Investment Management sold 900 Vertex Pharmaceuticals shares in Q2 2026, an estimated $399K.
  • Vertex Pharmaceuticals made up 0.12% of Ipswich Investment Management's portfolio in Q2 2026, its #119 holding.
  • Ipswich Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • Ipswich Investment Management's Vertex Pharmaceuticals position peaked at $2.68M in Q1 2025.
  • 337 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.